These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis.
    Author: Corless JA, Warburton CJ.
    Journal: Cochrane Database Syst Rev; 2000; 2000(4):CD002174. PubMed ID: 11034744.
    Abstract:
    BACKGROUND: Leukotriene receptor antagonists are a new class of drug that were initially identified for use in asthma. As they have an effect on neutrophil mediated inflammation, they may be of benefit in bronchiectasis. OBJECTIVES: To determine whether leukotriene receptor antagonists have any additive benefit over and above conventional treatment for bronchiectasis (usually consisting of antibiotics and postural drainage). SEARCH STRATEGY: The Cochrane Airways Group clinical trials register derived from MEDLINE, EMBASE and hand searching of major journals was searched using the terms:Bronchiec* AND leukotrien* OR anti-leuk* OR cysteinyl, Bronchiec* AND monteluk*, Bronchiec* AND zafirluk* SELECTION CRITERIA: Only randomised, controlled trials were considered DATA COLLECTION AND ANALYSIS: The results of searches were analysed by both authors MAIN RESULTS: No randomised, controlled trials were identified REVIEWER'S CONCLUSIONS: Further research is required to establish any benefit from the use of leukotriene antagonists in bronchiectasis.
    [Abstract] [Full Text] [Related] [New Search]